Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Westermann

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
Cancer Research|October 7, 2004
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastomaJun S Wei, Braden T Greer, Frank Westermann, et al.
Human Molecular Genetics|August 9, 2014
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomasDaniel Dreidax, Steffen Bannert, Kai-Oliver Henrich, et al.
Nature Communications|December 16, 2018
Transcriptome 3'end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastomaAnton Ogorodnikov, Michal Levin, Surendra Tattikota, et al.
Nature Genetics|March 26, 2021
Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastomaSelina Jansky, Ashwini Kumar Sharma, Verena Körber, et al.
Nature Reviews. Cancer|July 14, 2019
Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumoursDavid T W Jones, Ana Banito, Thomas G P Grünewald, et al.
Oncotarget|August 18, 2016
Wnt signalling is a bi-directional vulnerability of cancer cellsDavid J Duffy, Aleksandar Krstic, Thomas Schwarzl, et al.
Oncoimmunology|July 7, 2017
Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expressionJulian P Layer, Marie T Kronmüller, Thomas Quast, et al.
Cancers|September 10, 2021
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for NeuroblastomaMichael Müller, Lisa Rösch, Sara Najafi, et al.
Cellular and Molecular Life Sciences : CMLS|February 17, 2019
Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastomaAroa Soriano, Marc Masanas, Ariadna Boloix, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastomaJohannes H Schulte, Hagen S Bachmann, Bent Brockmeyer, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
Cancer Research|October 7, 2004
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastomaJun S Wei, Braden T Greer, Frank Westermann, et al.
Human Molecular Genetics|August 9, 2014
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomasDaniel Dreidax, Steffen Bannert, Kai-Oliver Henrich, et al.
Nature Communications|December 16, 2018
Transcriptome 3'end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastomaAnton Ogorodnikov, Michal Levin, Surendra Tattikota, et al.
Nature Genetics|March 26, 2021
Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastomaSelina Jansky, Ashwini Kumar Sharma, Verena Körber, et al.
Nature Reviews. Cancer|July 14, 2019
Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumoursDavid T W Jones, Ana Banito, Thomas G P Grünewald, et al.
Oncotarget|August 18, 2016
Wnt signalling is a bi-directional vulnerability of cancer cellsDavid J Duffy, Aleksandar Krstic, Thomas Schwarzl, et al.
Oncoimmunology|July 7, 2017
Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expressionJulian P Layer, Marie T Kronmüller, Thomas Quast, et al.
Cancers|September 10, 2021
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for NeuroblastomaMichael Müller, Lisa Rösch, Sara Najafi, et al.
Cellular and Molecular Life Sciences : CMLS|February 17, 2019
Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastomaAroa Soriano, Marc Masanas, Ariadna Boloix, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastomaJohannes H Schulte, Hagen S Bachmann, Bent Brockmeyer, et al.
Pageof 14